𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease

✍ Scribed by Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H. H. Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P. Schanstra

Publisher
Springer
Year
2010
Tongue
English
Weight
183 KB
Volume
25
Category
Article
ISSN
0931-041X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteomics of human cerebrospinal fluid:
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
✍ A.C. Kroksveen; J.A. Opsahl; T.T. Aye; R.J. Ulvik; F.S. Berven 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 737 KB

There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases. Cerebrospinal fluid (CSF) is in direct contact with the CNS and reflects

Upfront, randomized, phase 2 trial of so
Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma : Clinical and biomarker analysis
✍ Eric Jonasch; Paul Corn; Lance C. Pagliaro; Carla L. Warneke; Marcella M. Johnso 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Abstract ## BACKGROUND: The objective of this study was to independently evaluate the objective response rate of sorafenib and sorafenib plus low‐dose interferon‐alfa 2b (IFN) as frontline therapy in patients with metastatic renal cell carcinoma (mRCC). ## METHODS: Untreated patients with cle